Axi-cel in CNS Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Haploidentical HCT for Severe Aplastic Anemia
- Status
- RECRUITING
- Phase
- PHASE2
FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab
- Status
- WITHDRAWN
- Phase
- PHASE2
Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
- Status
- RECRUITING
- Phase
- PHASE1
Haplo Peripheral Blood Sct In GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE1
Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE2
Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML
- Status
- WITHDRAWN
- Phase
- PHASE2